• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Labetalol: bioavailability, drug plasma levels, plasma renin and catecholamines in acute and chronic treatment of resistant hypertension.

作者信息

Louis W J, Christophidis N, Brignell M, Vijayasekaran V, McNeil J, Vajda F J

出版信息

Aust N Z J Med. 1978 Dec;8(6):602-9. doi: 10.1111/j.1445-5994.1978.tb04847.x.

DOI:10.1111/j.1445-5994.1978.tb04847.x
PMID:285681
Abstract
摘要

相似文献

1
Labetalol: bioavailability, drug plasma levels, plasma renin and catecholamines in acute and chronic treatment of resistant hypertension.拉贝洛尔：在顽固性高血压急性和慢性治疗中的生物利用度、药物血浆水平、血浆肾素和儿茶酚胺
Aust N Z J Med. 1978 Dec;8(6):602-9. doi: 10.1111/j.1445-5994.1978.tb04847.x.
2
Labetalol in the treatment of severe essential hypertension: relationship between arterial blood pressure, plasma catecholamines, plasma renin activity, plasma aldosterone and body weight.拉贝洛尔治疗重度原发性高血压：动脉血压、血浆儿茶酚胺、血浆肾素活性、血浆醛固酮与体重之间的关系
Acta Med Scand Suppl. 1979;625:59-64. doi: 10.1111/j.0954-6820.1979.tb00743.x.
3
Effects of labetalol on plasma renin, aldosterone, and catecholamines in hypertensive patients.拉贝洛尔对高血压患者血浆肾素、醛固酮和儿茶酚胺的影响。
J Cardiovasc Pharmacol. 1979 Nov-Dec;1(6):625-32. doi: 10.1097/00005344-197911000-00003.
4
The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol.食物对高清除率药物口服及静脉药代动力学的影响：拉贝洛尔的研究
Br J Clin Pharmacol. 1982 Jul;14(1):73-8. doi: 10.1111/j.1365-2125.1982.tb04936.x.
5
Decreased first-pass metabolism of labetalol in chronic liver disease.慢性肝病中拉贝洛尔首过代谢降低。
Br Med J. 1978 Oct 14;2(6144):1048-50. doi: 10.1136/bmj.2.6144.1048.
6
Effect of oral labetalol on plasma catecholamines, renin and aldosterone in patients with severe arterial hypertension.口服拉贝洛尔对重度动脉高血压患者血浆儿茶酚胺、肾素和醛固酮的影响。
Eur J Clin Pharmacol. 1979 Nov;16(5):305-10. doi: 10.1007/BF00605626.
7
Plasma catecholamines, renin and aldosterone during combined alpha- and beta- adrenoceptor blockade in patients with severe arterial hypertension.重度动脉高血压患者联合α和β肾上腺素能受体阻滞剂治疗期间的血浆儿茶酚胺、肾素和醛固酮水平
Postgrad Med J. 1980;56 Suppl 2:49-52.
8
Intravenous dilevalol. Effects of the R-R optical isomer of labetalol in patients with severe hypertension.静脉注射双醋洛尔。拉贝洛尔的R-R光学异构体对重度高血压患者的影响。
Arch Intern Med. 1988 Mar;148(3):534-8. doi: 10.1001/archinte.148.3.534.
9
Single-dose pharmacokinetics of labetalol in healthy young men.拉贝洛尔在健康年轻男性中的单剂量药代动力学。
Acta Med Scand Suppl. 1982;665:67-73. doi: 10.1111/j.0954-6820.1982.tb00410.x.
10
The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels.拉贝洛尔的急性和慢性降压作用及其与治疗前血浆去甲肾上腺素水平的关系。
Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):87S-92S. doi: 10.1111/j.1365-2125.1982.tb01894.x.

引用本文的文献

1
Effects of chronic alpha and beta adrenoceptor blockade with labetalol on plasma catecholamines and renal function in hypertension.拉贝洛尔长期α和β肾上腺素能受体阻滞对高血压患者血浆儿茶酚胺及肾功能的影响
Klin Wochenschr. 1980 Jan 2;58(1):25-9. doi: 10.1007/BF01477140.
2
Elimination kinetics of labetalol in severe renal failure.重度肾衰竭患者中拉贝洛尔的消除动力学
Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):81S-86S. doi: 10.1111/j.1365-2125.1982.tb01893.x.
3
Labetalol steady-state pharmacokinetics in hypertensive patients.高血压患者中拉贝洛尔的稳态药代动力学
Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):75S-80S. doi: 10.1111/j.1365-2125.1982.tb01892.x.
4
Labetolol in patients with hypertension and varying degrees of renal impairment.拉贝洛尔用于患有高血压及不同程度肾功能损害的患者。
Ir J Med Sci. 1984 Oct;153(10):336-42. doi: 10.1007/BF02939928.
5
Clinical pharmacokinetics of labetalol.拉贝洛尔的临床药代动力学
Clin Pharmacokinet. 1984 Mar-Apr;9(2):157-67. doi: 10.2165/00003088-198409020-00003.
6
Pharmacology of combined alpha-beta-blockade. I.α-β联合阻滞的药理学。I.
Drugs. 1984;28 Suppl 2:16-34. doi: 10.2165/00003495-198400282-00003.
7
Pharmacokinetics and systemic availability of the antihypertensive agent indoramin and its metabolite 6-hydroxyindoramin in healthy subjects.
Eur J Clin Pharmacol. 1987;32(6):619-23. doi: 10.1007/BF02455999.
8
Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease.拉贝洛尔：对其药理学、药代动力学以及在高血压和缺血性心脏病治疗中的应用的重新评估。
Drugs. 1989 May;37(5):583-627. doi: 10.2165/00003495-198937050-00002.
9
The effects of a single dose of dilevalol on [3H]-noradrenaline plasma kinetics and plasma lipoprotein cholesterol concentrations.单次剂量双醋洛尔对[3H]-去甲肾上腺素血浆动力学及血浆脂蛋白胆固醇浓度的影响。
Br J Clin Pharmacol. 1990 Mar;29(3):281-7. doi: 10.1111/j.1365-2125.1990.tb03637.x.
10
Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects.拉贝洛尔在高血压患者中的药代动力学和药效学研究。
Br J Clin Pharmacol. 1979;8(Suppl 2):157S-161S.